Researchers at the National Institutes of Health found that living in an area with high levels of particulate air pollution was associated with an increased incidence of breast cancer.
Astellas seeks approval for PADCEV-KEYTRUDA combo
Share this article The sNDA is based on the Phase III EV-302 clinical trial. Credit: totojang1977/ shutterstock.com. Astellas Pharma has submitted a supplemental new drug